Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic precision and accuracy in interpretation of specimens from cancer screening programs.

Elliott Foucar1

  • 1Foucell@aol.com

Seminars in Diagnostic Pathology
|April 28, 2006
PubMed
Summary

Cancer screening, like the Papanicolaou (Pap) test, reduces invasive cancer incidence. However, accurately diagnosing early neoplastic changes presents statistical and ethical challenges for pathologists.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Cue-Based Strategies in Skilled Diagnosis Among Pathologists.

Human factors·2021
Same author

DCIS and invasive interval breast cancer.

The Lancet. Oncology·2016
Same author

Pathologic Abnormalities Behind Ductal Carcinoma In Situ Terminology.

JAMA oncology·2016
Same author

Addressing overdiagnosis and overtreatment in cancer.

The Lancet. Oncology·2014
Same author

The pathologist in tortland: when is ignorance about "med-mal" rational, when is it unavoidable, and when is it a problem to be corrected?

American journal of clinical pathology·2014
Same author

Case 8-2013: A woman with carcinoma in situ of the breast.

The New England journal of medicine·2013

Area of Science:

  • Anatomic pathology
  • Medical screening
  • Diagnostic accuracy

Background:

  • Anatomic pathology classifications of malignancies are evidence-based.
  • The Papanicolaou (Pap) test demonstrated screening's efficacy in reducing invasive cervical cancer.
  • Cancer screening programs generate specimens with early neoplastic changes.

Purpose of the Study:

  • To discuss the challenges in translating morphologic findings from cancer screening into risk estimates.
  • To explore the statistical and ethical problems associated with diagnostic thresholds in screening.
  • To highlight the 'screening paradox' faced by pathologists.

Main Methods:

  • Review of morphologic tools applied in cancer screening.
  • Analysis of diagnostic threshold implications (specificity vs. sensitivity).

Related Experiment Videos

  • Discussion of challenges in identifying early neoplastic transformations.

    • Main Results:

    • Cancer screening has revolutionized pathology specimen types.
    • Setting diagnostic thresholds involves trade-offs between false negatives and false positives.
    • Early neoplastic changes are inherently difficult to identify with precision.

    Conclusions:

    • Pathologists face a paradox when screening for early neoplastic changes.
    • Balancing sensitivity and specificity in screening tests is a significant challenge.
    • Accurate interpretation of screening specimens is crucial but complex.